Mayra Mejía Selected Research

Antigens

1/2006

Hypersensitivity pneumonitis : a broader perspective.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mayra Mejía Research Topics

Disease

9	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 03/2012
5	Rheumatoid Arthritis 11/2020 - 03/2012
3	Antisynthetase syndrome 01/2022 - 01/2020
3	Arthritis (Polyarthritis) 01/2022 - 01/2017
3	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 10/2019
2	COVID-19 04/2022 - 01/2022
2	Respiratory Tract Diseases (Respiratory Tract Disease) 08/2021 - 01/2021
2	Disease Progression 07/2020 - 01/2020
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2020 - 10/2019
2	Lung Diseases (Lung Disease) 07/2017 - 09/2014
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Fever (Fevers) 01/2022
1	Infections 08/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 02/2021
1	Dysbiosis 07/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Raynaud Disease (Raynaud's Disease) 01/2020
1	Idiopathic Pulmonary Fibrosis 12/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2017
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 09/2015
1	Fibrosis (Cirrhosis) 01/2015
1	Cough 01/2006
1	Dyspnea (Shortness of Breath) 01/2006

Drug/Important Bio-Agent (IBA)

5	AutoantibodiesIBA 01/2022 - 01/2017
3	AntibodiesIBA 11/2020 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 08/2021
2	Transfer RNA (tRNA)IBA 01/2022 - 02/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2020
2	Methotrexate (Mexate)FDA LinkGeneric 07/2017 - 09/2014
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Amino Acids FDA Link 08/2021
1	Angiotensin-Converting Enzyme 2IBA 08/2021
1	EnzymesIBA 08/2021
1	Ligases (Synthetase)IBA 02/2021
1	C-Reactive ProteinIBA 11/2020
1	CreatinineIBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	HLA-DRB1*03:01 antigenIBA 01/2020
1	NucleotidesIBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 10/2019
1	P-2 (P 2)IBA 12/2018
1	Phosphotransferases (Kinase)IBA 01/2017
1	Procollagen Type IIBA 09/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Anti-Citrullinated Protein AntibodiesIBA 01/2015
1	AntigensIBA 01/2006

Therapy/Procedure

2	Artificial Respiration (Mechanical Ventilation) 04/2022 - 01/2022
1	Transplantation 11/2020
1	Duration of Therapy 01/2015
1	Aftercare (After-Treatment) 03/2012